BAYER AG |
Market Closed -
Other stock markets
|
After market 03:58:00 pm | |||
| 26.24 EUR | -0.04% |
|
26.28 | +0.13% |
| 02:39pm | Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation | MT |
| 12:18pm | Bayer: fast-track procedure in cardiology in the USA | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.25
EUR
Average target price
37.05
EUR
Spread / Average Target
+41.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.97% | 27.44B | |
| +27.81% | 676B | |
| +23.58% | 554B | |
| -7.19% | 349B | |
| +14.85% | 318B | |
| +6.36% | 291B | |
| +2.96% | 210B | |
| -0.41% | 204B | |
| -10.02% | 194B | |
| -11.84% | 144B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer : Seeks Approval For Cancer Treatment Combinations In US, EU
